Skip to main content
survivor and child

Cancer Health Outcomes & Control Research Program

The Cancer Health Outcomes and Control Program conducts research aimed at reducing the burden of cancer across the entire cancer care continuum. The research efforts of this interdisciplinary, collaborative program center on the themes of: 

  • Prevention and Early Detection
  • Treatment-Related Outcomes
  • Survivorship and Palliative Care

RESEARCH THEMES

The Cancer Health Outcomes and Control Program aims to achieve the goal of reducing the cancer burden through:

Establishing and further developing population and community-based resources for research into prevention and short and long-term outcomes

Identifying environmental, sociobehavioral and genetic factors that affect short- and long-term outcomes

Understanding the scope of and developing interventions to prevent or ameliorate adverse long-term patient-centered outcomes following cancer diagnosis and treatment

Assessing the magnitude and determinants of disparities in cancer control and outcomes associated with age, race, gender, geography and other group characteristics and developing interventions to decrease such disparities

Meet the Program Members

Debra Friedman, M.D., David Penson, M.D., M.P.H., and Pierre Massion, M.D., co-lead the Cancer Health Outcomes and Control program. The program maintains close alliances with other cancer center programs, including population science partner program, Cancer Epidemiology, and the basic and clinical science programs. Extensive collaborations with community partners—including Meharry Medical College, Tennessee State University, federally qualified community health centers and oncologists at affiliate institutions, and other academic centers—extend the program's impact in the community and foster multi-institution research.


Featured Publications

Program News

May 7, 2020

Study finds AI can categorize cancer risk of lung nodules

Computed tomography scans for people at risk for lung cancer lead to earlier diagnoses and improve survival rates, but they can also lead to overtreatment when suspicious nodules turn out to be benign.
April 9, 2020

Study tracks genomics of lung tumor behavior

A study by Vanderbilt researchers has identified genomic alterations in early stage adenocarcinomas of the lung that may indicate whether the lesions develop into aggressive tumors.
January 2, 2020

Study examines prostate cancer treatment decisions

A five-year follow-up study of U.S. men who received prostate cancer treatment is creating a road map for future patients to clarify expectations and enable men to make informed choices about care.